References
Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thrombos Haemostas 45: 200–203
Green D, Schuette PT, Wallace WH (1980) Factor VIII antibodies in rheumatoid arthritis (effect of cyclophosphamide) Arch Intern Med 140: 1232–1235
Gianelli-Borradori A, Hirt A, Lüthy A, Wagner HP, Imbach P (1984) Haemophilia due to factor VIII inhibitors in a patient suffering from an autoimmune disease: Treatment with intravenous immunoglobulin. Blut 48: 403–407
Herbst K, Rapaport SJ, Kenoyer DG, Stanton W, Feinstein DJ (1981) Syndrome of an acquired inhibitor of factor VIII response to cyclophosphamide and prednisone. Ann Intern Med 95: 575–578
Imbach P, Barandun S, Baumgartner G, Gaedicke G, Hirt A, Wagner HP (1984) Intravenous immunoglobulin therapy: New aspects and outlock. Blut 48: 415–418
Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet I: 1228–1231
Jungi TW, Imbach P, Barandun S (1984) Specific and nonspecific mechanisms of action of immunoglobulin G in therapy of idiopathic thrombocytopenic purpura (ITP) Blut 48: 345–351
Kasper CK (1981) Management of inhibitors to factor VIII. In: Brown EB (ed) Progress in Hematology Vol XII. Grune and Stratton, New York London Paris, pp 143–163
Seifried E, Gaedicke G, Pindur G, Rasche H (1984) The treatment of haemophilia A inhibitor with high dose intravenous immunoglobulin. Blut 48: 397–401
Sultan Y, Maisonneuve P, Kazatchkine MD, Nydegger UE (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet II: 765–768
Wensley RT, Stevens RF, Burn AM, Delamore IW (1980) Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors. Br Med J 281: 1388–1389
Zimmermann R, Kommerell B, Harenberg J, Eich W, Rother K, Schimpf KL (1985) Intravenous IgG for patients with spontaneous inhibitor to factor VIII. Lancet I: 273–274
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hiller, E., Holler, E., Geursen, R.G. et al. Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII. Blut 52, 123–126 (1986). https://doi.org/10.1007/BF00321075
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00321075